Total Payments
$65,937
2024 Payments
$14,013
Companies
7
Transactions
104
Medicare Patients
540
Medicare Billing
$60,826
Payment Breakdown by Category
Other$54,876 (83.2%)
Consulting$5,584 (8.5%)
Travel$2,502 (3.8%)
Food & Beverage$1,870 (2.8%)
Education$1,106 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54,876 | 42 | 83.2% |
| Consulting Fee | $5,584 | 3 | 8.5% |
| Travel and Lodging | $2,502 | 18 | 3.8% |
| Food and Beverage | $1,870 | 25 | 2.8% |
| Education | $1,106 | 16 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $33,403 | 57 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $19,054 | 26 | $0 (2024) |
| ABBVIE INC. | $9,908 | 8 | $0 (2024) |
| Melinta Therapeutics, LLC | $3,520 | 10 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26.66 | 1 | $0 (2019) |
| bioMerieux Inc | $12.90 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $12.70 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,013 | 18 | ABBVIE INC. ($8,408) |
| 2023 | $13,566 | 19 | Ferring Pharmaceuticals Inc. ($13,529) |
| 2022 | $4,294 | 6 | Melinta Therapeutics, LLC ($2,754) |
| 2021 | $2,152 | 8 | Astellas Pharma US Inc ($1,433) |
| 2020 | $5,499 | 7 | Astellas Pharma US Inc ($5,499) |
| 2019 | $15,086 | 25 | Astellas Pharma US Inc ($15,024) |
| 2018 | $3,272 | 7 | Astellas Pharma US Inc ($3,272) |
| 2017 | $8,055 | 14 | Astellas Pharma US Inc ($8,055) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/05/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,151.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $124.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/29/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $116.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/15/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,629.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $260.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $164.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $29.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/08/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $11.08 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/07/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $38.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/17/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/24/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $116.58 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/24/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $102.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/12/2024 | ABBVIE INC. | DALVANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,025.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $44.99 | General |
| 04/11/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $34.99 | General |
| 03/26/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $116.58 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/26/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/26/2024 | ABBVIE INC. | DALVANCE (Drug) | Travel and Lodging | In-kind items and services | $3.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/19/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Consulting Fee | Cash or cash equivalent | $2,390.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/30/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $5.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/24/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $717.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/05/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Education | In-kind items and services | $580.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/13/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $4.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/06/2023 | bioMerieux Inc | — | Food and Beverage | In-kind items and services | $12.90 | General |
| 07/18/2023 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,151.00 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 97 | 125 | $22,154 | $10,614 |
| 2022 | 4 | 113 | 151 | $25,866 | $12,363 |
| 2021 | 4 | 142 | 186 | $31,813 | $15,049 |
| 2020 | 5 | 188 | 280 | $46,323 | $22,800 |
Total Patients
540
Total Services
742
Medicare Billing
$60,826
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 37 | $6,222 | $3,356 | 53.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 49 | $5,713 | $2,913 | 51.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 24 | $5,308 | $2,443 | 46.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 15 | 15 | $4,911 | $1,902 | 38.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 38 | 69 | $8,045 | $3,856 | 47.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 38 | $6,390 | $3,052 | 47.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 28 | 28 | $6,193 | $2,966 | 47.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 16 | 16 | $5,239 | $2,488 | 47.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 34 | 56 | $9,417 | $4,375 | 46.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 41 | 41 | $9,068 | $4,318 | 47.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 53 | 75 | $8,744 | $4,130 | 47.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 14 | 14 | $4,584 | $2,227 | 48.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 45 | 85 | $14,294 | $7,011 | 49.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 62 | 108 | $12,592 | $6,249 | 49.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 44 | 48 | $10,617 | $5,174 | 48.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 23 | 24 | $7,858 | $3,896 | 49.6% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 14 | 15 | $963.24 | $469.59 | 48.8% |
About Dr. Emil Lesho, D.O
Dr. Emil Lesho, D.O is a Infectious Disease healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982622536.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Emil Lesho, D.O has received a total of $65,937 in payments from pharmaceutical and medical device companies, with $14,013 received in 2024. These payments were reported across 104 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($54,876).
As a Medicare-enrolled provider, Lesho has provided services to 540 Medicare beneficiaries, totaling 742 services with total Medicare billing of $60,826. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Rochester, NY
- Active Since 07/18/2006
- Last Updated 01/02/2018
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1982622536
Products in Payments
- REBYOTA (Biological) $19,054
- CRESEMBA (Drug) $12,260
- DALVANCE (Drug) $9,908
- Cresemba (Drug) $3,697
- Kimyrsa (Drug) $2,492
- Orbactiv (Drug) $525.00
- Vabomere (Drug) $502.70
- MYRBETRIQ (Drug) $26.88
- JARDIANCE (Drug) $26.66
- ZERBAXA (Drug) $12.70
- LEXISCAN (Drug) $3.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Rochester
Robin Patel, M.d, M.D
Infectious Disease — Payments: $270,548
Infectious Disease $270,548
Ann Falsey, Md, MD
Infectious Disease — Payments: $191,692
Infectious Disease $191,692
Edward Walsh, Md, MD
Infectious Disease — Payments: $131,419
Infectious Disease $131,419
Zelalem Temesgen, M.d, M.D
Infectious Disease — Payments: $56,223
Infectious Disease $56,223
Dr. Angela Branche, Md, MD
Infectious Disease — Payments: $50,957
Infectious Disease $50,957
William Valenti, Md, MD
Infectious Disease — Payments: $38,806
Infectious Disease $38,806